Abstract
Acrolein (ACR) is a highly reactive α, β-unsaturated carbonyl compound that is related to several diabetic vascular complications. ACR, a ubiquitous aldehyde pollutant, is a product of incomplete combustion reactions and a major component of cigarette smoke. ACR is also endogenously generated during lipid peroxidation. Glycosylphosphatidylinositol (GPI)-anchored proteins is a membrane bound protein, which have a variety of cellular functions. It is reported that some of them showed the reduced level under diabetic conditions. In this study, we explored whether ACR may affect GPI anchor related gene expression in human umbilical vein endothelial cells (HUVECs) by modulation of miRNA expression that play a significant role in the post-transcriptional regulation of genes. We performed global gene expression analysis, acquired altered expression levels of 27 miRNAs and 21 mRNAs that are relevant to GPI anchored proteins, and observed their anti-correlations. Gene Ontology (GO) terms that are closely associated with GPI anchor biosynthesis were highest when analysis was based on biological processes characterized by enriched GO categories. Our results revealed that ACR may control miRNAs to regulate genes involving in GPI anchor biosynthesis in human endothelial cells.
Similar content being viewed by others
References
Negre-Salvayre, A., Coatrieux, C., Ingueneau, C. & Salvayre, R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br. J. Pharmacol. 153, 6–20 (2008).
LoPachin, R.M., Barber, D.S. & Gavin, T. Molecular mechanisms of the conjugated alpha, beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases. Toxicol. Sci. 104, 235–249 (2008).
Kirkham, P.A. et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 184, 796–802 (2011).
Suzuki, D. & Miyata, T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern. Med. 38, 309–314 (1999).
Ethen, C.M., Reilly, C., Feng, X., Olsen, T.W. & Ferrington, D.A. Age-related macular degeneration and retinal protein modification by 4-hydroxy-2-nonenal. Invest. Ophthalmol. Vis. Sci. 48, 3469–3479 (2007).
Lee, S.E. et al. Upregulation of heme oxygenase-1 as an adaptive mechanism for protection against crotonaldehyde in human umbilical vein endothelial cells. Toxicol. Lett. 201, 240–248 (2011).
Lee, S.E. et al. Induction of heme oxygenase-1 inhibits cell death in crotonaldehyde-stimulated HepG2 cells via the PKC-delta-p38-Nrf2 pathway. PLoS One 7, e41676 (2012).
Lu, J. et al. Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathy. Clin. Biochem. 44, 307–311 (2011).
Daimon, M. et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr. J. 50, 61–67 (2003).
Toyokuni, S. et al. Serum 4-Hydroxy-2-Nonenal-Modified Albumin Is Elevated in Patients with Type 2 Diabetes Mellitus. Antioxid. Redox Signal. 2, 681–685 (2000).
Jeong, S.I. et al. Genome-wide analysis of gene expression by crotonaldehyde in human umbilical vein endothelial cells. Mol. Cell. Toxicol. 7, 127–134 (2011).
Carmella, S.G. et al. Quantitation of acrolein-derived (3-hydroxypropyl) mercapturic acid in human urine by liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Effects of cigarette smoking. Chem. Res. Toxicol. 20, 986–990 (2007).
Esterbauer, H., Schaur, R.J. & Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81–128 (1991).
Jeong, S.I. et al. Effect of alpha, beta-unsaturated aldehydes on endothelial cell growth in bacterial cellulose for vascular tissue engineering. Mol. Cell. Toxicol. 8, 119–126 (2012).
Park, Y.S. & Taniguchi, N. Acrolein induces inflammatory response underlying endothelial dysfunction: a risk factor for atherosclerosis. Ann. N. Y. Acad. Sci. 1126, 185–189 (2008).
Lee, N.J. et al. Upregulation of Heme Oxygenase-1 as an Adaptive Mechanism against Acrolein in RAW 264.7 Macrophages. Mol. Cell. Toxicol. 5, 230–236 (2009).
Tsukahara, H. et al. Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes. Pediatr. Res. 54, 419–424 (2003).
Daimon, M. et al. Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes. Endocr. J. 50, 61–67 (2003).
Noiri, E. et al. Serum protein acrolein adducts: Utility in detecting oxidant stress in hemodialysis patients and reversal using a vitamin E-bonded hemodialyzer. Free Radical. Biol. Med. 33, 1651–1656 (2002).
Hamada, Y. & Fukagawa, M. A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J. Med. Sci. 53, 53–61 (2007).
Uchida, K. et al. Protein-bound acrolein: potential markers for oxidative stress. Proc. Natl. Acad. Sci. USA 95, 4882–4887 (1998).
Park, Y.S. et al. Acrolein induces cyclooxygenase-2 and prostaglandin production in human umbilical vein endothelial cells: roles of p38 MAP kinase. Arterioscler. Thromb. Vasc. Biol. 27, 1319–1325 (2007).
Orlean, P. & Menon, A.K. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J. Lipid Res. 48, 993–1011 (2007).
Ferguson, M.A. & Williams, A.F. Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. Annu. Rev. Biochem. 57, 285–320 (1988).
Orlean, P. & Menon, A.K. Thematic review series: lipid posttranslational modifications. GPI anchoring of protein in yeast and mammalian cells, or: how we learned to stop worrying and love glycophospholipids. J. Lipid. Res. 48, 993–1011 (2007).
Lisanti, M.P., Rodriguez-Boulan, E. & Saltiel, A.R. Emerging functional roles for the glycosyl-phosphatidylinositol membrane protein anchor. J. Membr. Biol. 117, 1–10 (1990).
Yang, H. et al. Differentially-expressed genes associated with glycophosphatidylinositol (GPI)-anchored proteins by diabetes-related toxic substances in human endothelial cells. BioChip J. 6, 262–270 (2012).
Accardo-Palumbo, A. et al. Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells. Diabetologia 43, 1039–1047 (2000).
Acosta, J. et al. Molecular basis for a link between complement and the vascular complications of diabetes. Proc. Natl. Acad. Sci. USA 97, 5450–5455 (2000).
Skillen, A.W., Hawthorne, G.C. & Turner, G.A. Serum alkaline phosphatase in rats with streptozotocin-induced diabetes. Horm. Metab. Res. 19, 505–506 (1987).
Lema, C. & Cunningham, M.J. MicroRNAs and their implications in toxicological research. Toxicol. Lett. 198, 100–105 (2010).
Sun, X. et al. MicroRNA-181b regulates NF-kappaBmediated vascular inflammation. J. Clin. Invest. 122, 1973–1990 (2012).
Caruso, P. et al. A Role for miR-145 in Pulmonary Arterial Hypertension: evidence from mouse models and patient samples. Circ. Res. 111, 290–300 (2012).
Asgeirsdottir, S.A. et al. MicroRNA-126 contributes to renal microvascular heterogeneity of VCAM-1 protein expression in acute inflammation. Am. J. Physiol. Renal. Physiol. 302, F1630–1639 (2012).
Bonauer, A., Boon, R.A. & Dimmeler, S. Vascular microRNAs. Curr. Drug Targets 11, 943–949 (2010).
Treguer, K., Heinrich, E.M., Ohtani, K., Bonauer, A. & Dimmeler, S. Role of the MicroRNA-17-92 Cluster in the Endothelial Differentiation of Stem Cells. J. Vasc. Res. 49, 447–460 (2012).
Yang, D.G., Liu, L. & Zhou, S.H. MicroRNA alterations in senescent endothelial progenitor cells induced by remnant-like lipoproteins. Chin. Med. J. (Engl) 125, 3479–3484 (2012).
Meng, S. et al. Downregulation of microRNA-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene Spred-1. J. Mol. Cell. Cardiol. 53, 64–72 (2012).
Lou, Y. et al. Microrna-210 modified human umbilical vein endothelial cells induce capillary formation. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 26, 587–591 (2012).
Jeong, S.I. et al. MicroRNA microarray analysis of human umbilical vein endothelial cells exposed to benzo(a)pyrene. BioChip J. 6, 191–196 (2012).
Cui, Y. et al. MicroRNA-181b and microRNA-9 mediate arsenic-induced angiogenesis via NRP1. J. Cell. Physio. 227, 772–783 (2012).
Hong, Y. et al. Requirement of PIG-F and PIG-O for transferring phosphoethanolamine to the third mannose in glycosylphosphatidylinositol. J. Biol. Chem. 275, 20911–20919 (2000).
Taron, B.W., Colussi, P.A., Wiedman, J.M., Orlean, P. & Taron, C.H. Human Smp3p adds a fourth mannose to yeast and human glycosylphosphatidylinositol precursors in vivo. J. Biol. Chem. 279, 36083–36092 (2004).
Yang, H. et al. Up-regulation of heme oxygenase-1 by Korean Red Ginseng water extract as a cytoprotective effect in human endothelial cells. J. Ginseng Res. 35, 352–359 (2011).
Yang, H. et al. Expression profile analysis of human umbilical vein endothelial cells treated with salvianolic acid B from Salvia miltiorrhiza. BioChip J. 5, 47–55 (2011).
Lee, S.E. et al. Genome-wide profiling in melatoninexposed human breast cancer cell lines identifies differentially methylated genes involved in the anticancer effect of melatonin. J. Pineal. Res. 54, 80–88 (2012).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, H., Lee, S.E., Lee, S. et al. Integrated analysis of miRNA and mRNA reveals that acrolein modulates GPI anchor biosynthesis in human primary endothelial cells. BioChip J 7, 11–16 (2013). https://doi.org/10.1007/s13206-013-7103-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13206-013-7103-1